AdvaMed Presses CMS On Open Payments Context, Dispute Resolutions
This article was originally published in The Gray Sheet
Executive Summary
As CMS moves forward to implement its Open Payments systems on physician payment reporting by month’s end, AdvaMed presses the agency to say how much contextual information will be included with the reports, and to make the system’s dispute and resolution process more efficient.
You may also be interested in...
Companies Dig Into Sunshine Rule Details In Preparation For Aug. 1 Go-Live Date
CMS has finalized several sunshine rule provisions: the definition of “applicable manufacturer” has been narrowed; many payments to speakers at continuing medical education programs and events need not be reported; and the agency will allow manufacturers to supply contextual information on the public database.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.